News Focus
News Focus
Followers 91
Posts 20561
Boards Moderated 0
Alias Born 09/06/2006

Re: KRISGO post# 758183

Tuesday, 04/01/2025 1:32:27 PM

Tuesday, April 01, 2025 1:32:27 PM

Post# of 818250

We should find a way to reach out to management and get clarity on the following:


One would normally expect a company to provide such information. This deal and details on the Roswell deal are things dev stage companies normally disclose in the corporate presentations.

Regardless, it sounds like a deal to buy Oncovir's Polyc-ICLC for trial use which would come with an agreement on commercial terms if things go well. I fail to see why the supposed -L + Poly trial would depend on the MAA outcome.

As far as the acquisition of another DC vaccine company, it would have to be a totally failed company for NWBO to afford it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News